Log in to save to my catalogue

Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systemati...

Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systemati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2654824899

Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis

About this item

Full title

Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European radiology, 2022-05, Vol.32 (5), p.3045-3055

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Objectives
Substantial inconsistencies exist in current guidelines regarding recommendations of metformin usage with the administration of a contrast medium. We aimed to perform a meta-analysis to determine whether the risks of contrast-induced acute kidney injury (CI-AKI) and lactic acidosis increase with metformin use in diabetic patients rece...

Alternative Titles

Full title

Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2654824899

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2654824899

Other Identifiers

ISSN

1432-1084,0938-7994

E-ISSN

1432-1084

DOI

10.1007/s00330-021-08395-7

How to access this item